期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
抑那通对子宫内膜异位症患者术后血清HE4及ENA78水平的影响 被引量:7
1
作者 李利玲 汪向红 +2 位作者 刘妮英 徐铮铮 王少帅 《现代生物医学进展》 CAS 2017年第12期2267-2270,共4页
目的:探究抑那通对子宫内膜异位症患者术后HE4、ENA78水平的影响及临床疗效。方法:选择我院收治的子宫内膜异位症患者64例,将其随机分成实验组及对照组。对照组31例予腹腔镜手术剥除异位囊肿,术后服用孕三烯酮胶囊治疗;实验组33例予腹... 目的:探究抑那通对子宫内膜异位症患者术后HE4、ENA78水平的影响及临床疗效。方法:选择我院收治的子宫内膜异位症患者64例,将其随机分成实验组及对照组。对照组31例予腹腔镜手术剥除异位囊肿,术后服用孕三烯酮胶囊治疗;实验组33例予腹腔镜手术剥除异位囊肿,术后辅以抑那通治疗。比较两组的临床疗效及治疗前后HE4、ENA78水平的变化。结果:实验组总有效率93.9%,显著高于对照组67.7%(P<0.05)。治疗后,两组血清卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)及人附睾蛋白4(HE4蛋白)、上皮中性粒细胞活化肽(ENA78)水平均较治疗前显著下降(P<0.05);与对照组比较,实验组血清FSH、LH、E2、HE4蛋白及ENA78水平较低,差异均具有统计学意义(P<0.05)。与对照组比较,实验组复发率较低、妊娠率较高(P<0.05)。结论:子宫内膜异位症患者在手术治疗后辅以抑那通治疗能够有效降低术后复发率,增高妊娠率,推测其机制与降低HE4及ENA78水平有关。 展开更多
关键词 子宫内膜异位症术后 抑那通 HE4 ena78
原文传递
Cell-free derivatives from mesenchymal stem cells are effective in wound therapy 被引量:3
2
作者 Pravin J Mishra Prasun J Mishra Debabrata Banerjee 《World Journal of Stem Cells》 SCIE CAS 2012年第5期35-43,共9页
AIM:To compare the efficacy of cell-free derivatives from Bone marrow derived human mesenchymal stem cells(hMSCs) in wound therapy.METHODS:hMSCs have been shown to play an important role in wound therapy.The present s... AIM:To compare the efficacy of cell-free derivatives from Bone marrow derived human mesenchymal stem cells(hMSCs) in wound therapy.METHODS:hMSCs have been shown to play an important role in wound therapy.The present study sought to compare efficacy of hMSCs and cell-free derivatives of hMSCs,which may be clinically more relevant as they are easier to prepare,formulate and transport.hMSCs were isolated from human bone marrow and cultured.Multi lineage differentiation of hMSCs was performed to confirm their identity.The ability of hMSCs to migrate was evaluated using in vitro and in vivo migration assays.Cell lysates and conditioned medium concentrate was prepared from hMSCs(see Methods for details).Wounds were induced in mice and wound areas were measure before and after cell and cell-free derivative treatment.RNA and proteins were extracted from the skin and cytokine levels were measured.RESULTS:Co-culture of hMSCs with keratinocytes resulted in increased expression of CXCL-12(SDF1) and ENA78(CXCL-5) in the conditioned media indicating that the hMSCs can respond to signals from keratinocytes.Accelerated wound closure was observed when hMSCs were injected near the site of excisional wounds in athymic as well as NOD/SCID mice.Interestingly,cell-free lysates prepared from hMSCs were also effective in inducing accelerated wound closure and increased expression of SDF1 and CXCL-5 at the wound bed.Additionally,concentrated media from hMSCs as well as an emulsion containing lysates prepared from hMSCs was also found to be more effective in rapid re-epithelialization than fibroblasts or vehicle-alone control.Use of cell-free derivatives may help replace expensive wound care approaches including use of growth factors,epidermal/dermal substitutes,synthetic membranes,cytokines,and matrix components,and most importantly avoid transmission of pathogens from human and animal products.CONCLUSION:These results encourage development of derivatives of hMSCs for wound care and re-epithelialization applications. 展开更多
关键词 STEM CELL DERIVATIVES KERATINOCYTE Mesenchymal STEM CELL Cytokine secretion WOUND healing SDF1 ena78 Animal models
下载PDF
趋化性细胞因子ENA-78与子宫内膜异位症的关系
3
作者 况燕 徐红 +3 位作者 何中慧 陈煜岊 梁秀就 覃锦耀 《中国妇幼保健》 CAS 北大核心 2009年第35期5063-5066,共4页
目的:检测子宫内膜异位症(EM)患者腹腔液中趋化性细胞因子ENA-78水平及ENA-78在异位组织中的表达,探讨趋化性细胞因子ENA-78在EM发病机制中的作用。方法:用酶联免疫吸附试验测定EM患者(实验组)和子宫肌瘤患者(对照组)腹腔液中ENA-78水平... 目的:检测子宫内膜异位症(EM)患者腹腔液中趋化性细胞因子ENA-78水平及ENA-78在异位组织中的表达,探讨趋化性细胞因子ENA-78在EM发病机制中的作用。方法:用酶联免疫吸附试验测定EM患者(实验组)和子宫肌瘤患者(对照组)腹腔液中ENA-78水平;同时采用免疫组化方法检测异位内膜组织与在位内膜组织ENA-78的蛋白表达。结果:①实验组腹腔液ENA-78水平显著高于对照组(P<0.05),并随着疾病的严重程度而增高(P<0.05);②ENA-78表达于异位腺体细胞、间质细胞及巨噬细胞的胞浆中,表达强度随着疾病的严重程度而增强(P<0.05),不同月经周期中ENA-78表达的差异无统计学意义(P>0.05);③EM患者在位内膜ENA-78表达较对照组强(P<0.05)。结论:ENA-78是一种重要的炎性介质,具有趋化并活化炎性细胞活性及促进异位内膜病灶血管增生,在EM的发生和发展各个环节均发挥作用,并随着疾病进展表达增强,是反映EM侵袭生长的生物学指标。 展开更多
关键词 子宫内膜异位症趋化性细胞因子ENA一78
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部